Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

NCT06804655 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT06804655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Recruiting
Start date
September 11, 2026
Completion date
September 15, 2028
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain (nervous system) cancers, ependymoma, glioblastoma, glioma, medulloblastoma, meningioma, rare cns primary tumors, rare primary brain tumors